Ruolin Wu
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Cancer-related gene regulation 2
- RNA modifications and cancer 2
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Lei Huang (2 shared papers)Aman Xu (1 shared paper)Hongchuan Zhao (9 shared papers)Xiaoping Geng (7 shared papers)Fan Huang (7 shared papers)Guobin Wang (8 shared papers)Xinghua Zhang (6 shared papers)Xiaojun Yu (2 shared papers)
In The Last Decade
Ruolin Wu
15 papers receiving 458 citations
Peers
Comparison fields: 5 of 80
- Hepatology 71
- Cancer Research 95
- Oncology 111
- Transplantation 7
- Molecular Biology 163
Countries citing papers authored by Ruolin Wu
This map shows the geographic impact of Ruolin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolin Wu more than expected).
Fields of papers citing papers by Ruolin Wu
This network shows the impact of papers produced by Ruolin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolin Wu. The network helps show where Ruolin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruolin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Epithelial-mesenchymal transition in gastric cancer. | 2015 | 222 |
| 2 | 2021 | 58 | |
| 3 | 2016 | 43 | |
| 4 | 2018 | 29 | |
| 5 | Inhibitor of DNA binding proteins: implications in human cancer progression and metastasis. | 2018 | 27 |
| 6 | 2020 | 22 | |
| 7 | 2016 | 17 | |
| 8 | 2024 | 13 | |
| 9 | 2021 | 9 | |
| 10 | 2022 | 8 | |
| 11 | 2023 | 5 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2013 | 1 | |
| 16 | 2025 | 0 |
About Ruolin Wu
Ruolin Wu is a scholar working on Molecular Biology, Oncology, Cancer Research, Hepatology and Surgery, having authored 16 papers that have together received 464 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer-related gene regulation (2 papers), RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer Mechanisms and Therapy (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Hepatology (71 citations), Cancer Research (95 citations), Oncology (111 citations), Transplantation (7 citations) and Molecular Biology (163 citations). Ruolin Wu has collaborated with scholars based in China, Germany and Hong Kong. Frequent co-authors include Lei Huang, Aman Xu, Hongchuan Zhao, Xiaoping Geng, Fan Huang, Guobin Wang, Xinghua Zhang, Xiaojun Yu, Mohammed Abba and Jing Ke. Their work appears in journals such as Applied Clay Science, Medicine, Transplant Immunology, Frontiers in Oncology and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.